Pabari R - Search Results

1

Targeting the 19S proteasomal subunit, Rpt4, for the treatment of colon cancer.

Boland K, Flanagan L, McCawley N, Pabari R, Kay EW, McNamara DA, Murray F, Byrne AT, Ramtoola Z, Concannon CG, Prehn JH. Boland K, et al. Among authors: pabari r. Eur J Pharmacol. 2016 Jun 5;780:53-64. doi: 10.1016/j.ejphar.2016.03.031. Epub 2016 Mar 17. Eur J Pharmacol. 2016. PMID: 26997367

2

Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.

Kirby BP, Pabari R, Chen CN, Al Baharna M, Walsh J, Ramtoola Z. Kirby BP, et al. Among authors: pabari r. J Pharm Pharmacol. 2013 Oct;65(10):1473-81. doi: 10.1111/jphp.12125. Epub 2013 Aug 1. J Pharm Pharmacol. 2013. PMID: 24028614

3

Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.

Pabari RM, Ramtoola Z. Pabari RM, et al. Int J Pharm. 2012 Jul 1;430(1-2):18-25. doi: 10.1016/j.ijpharm.2012.03.021. Epub 2012 Mar 20. Int J Pharm. 2012. PMID: 22465631 Free article.

4

Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.

O'Donnell A, Moollan A, Baneham S, Ozgul M, Pabari RM, Cox D, Kirby BP, Ramtoola Z. O'Donnell A, et al. J Pharm Pharmacol. 2015 Apr;67(4):525-36. doi: 10.1111/jphp.12347. Epub 2014 Dec 17. J Pharm Pharmacol. 2015. PMID: 25515568

5

Investigation of a novel 3-fluid nozzle spray drying technology for the engineering of multifunctional layered microparticles.

Pabari RM, Sunderland T, Ramtoola Z. Pabari RM, et al. Expert Opin Drug Deliv. 2012 Dec;9(12):1463-74. doi: 10.1517/17425247.2012.734295. Epub 2012 Oct 13. Expert Opin Drug Deliv. 2012. PMID: 23061546

6

Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.

Gowda V, Pabari RM, Kelly JG, Ramtoola Z. Gowda V, et al. Pharm Dev Technol. 2015 Jun;20(4):394-400. doi: 10.3109/10837450.2013.871031. Epub 2014 Jan 8. Pharm Dev Technol. 2015. PMID: 24397821

7

Effect of Thermal and Shear Stressors on the Physical Properties, Structural Integrity and Biological Activity of the Anti-TNF-alpha Monoclonal Antibody, Infliximab.

Alsaddique JA, Pabari RM, Ramtoola Z. Alsaddique JA, et al. Curr Pharm Biotechnol. 2016;17(10):905-14. doi: 10.2174/1389201017666160519111815. Curr Pharm Biotechnol. 2016. PMID: 27194359

8

Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.

Pabari RM, McDermott C, Barlow J, Ramtoola Z. Pabari RM, et al. Clin Ther. 2012 Nov;34(11):2221-9. doi: 10.1016/j.clinthera.2012.10.005. Clin Ther. 2012. PMID: 23149007

9

Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions.

Pabari RM, Ryan B, Ahmad W, Ramtoola Z. Pabari RM, et al. Curr Pharm Biotechnol. 2013;14(2):220-5. doi: 10.2174/138920113805219322. Curr Pharm Biotechnol. 2013. PMID: 23360264 Free article.

10

Effect of microencapsulation shear stress on the structural integrity and biological activity of a model monoclonal antibody, trastuzumab.

Pabari RM, Ryan B, McCarthy C, Ramtoola Z. Pabari RM, et al. Pharmaceutics. 2011 Aug 24;3(3):510-24. doi: 10.3390/pharmaceutics3030510. Pharmaceutics. 2011. PMID: 24310594 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters